PollNowData
Back to companies

Opus Genetics, Inc.

IRDUSNASDAQPharmaceuticals & Healthcare

Opus Genetics, Inc.

Revenue
$14.2mn
YoY +29.1%
Operating income
-$38.6mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API